ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,318.40
0.79%
S&P ASX All Technology
3,589.70
1.09%
Brent Oil
73.565
-1.80%
US Dollar vs AUD
1.48815
0.06%
Bitcoin
65,839.38
-0.33%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX

  6. Mayne Pharma Group Ltd (MYX) Share Price

Mayne Pharma Group Ltd

Mayne Pharma Group Ltd (MYX)

Mycelx Technologies Corporation
4.855
0.245
(5.31%)
Closed 16 October 4:00PM
Delayed by 20 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
4.855
Bid
4.81
Offer
4.87
Volume
234,957
4.55 Day's Range 4.90
2.75 52 Week Range 7.46
Market Cap
413.036M
Previous Close
4.61
Open
4.65
Last Trade
6
@
4.82
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
164,024
Shares Outstanding
85,074,288
Dividend Yield
-
PE Ratio
-2.45
Earnings Per Share (EPS)
-1.98
Revenue
388.4M
Net Profit
-168.62M

About Mayne Pharma Group Ltd

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.maynepharma.com
Headquarters
Adelaide, South Australia, Aus
Founded
-
Mayne Pharma Group Ltd is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker MYX. The last closing price for Mayne Pharma was AUD4.61. Over the last year, Mayne Pharma shares have traded in a share price range of AUD 2.75 to AUD 7.46.

Mayne Pharma currently has 85,074,288 shares in issue. The market capitalisation of Mayne Pharma is AUD392.19 million. Mayne Pharma has a price to earnings ratio (PE ratio) of -2.45.

Ask ADVFN Intelligence (AI)

MYX Latest News

More News

Mayne Pharma Launches Foam Dermatology Products in US

By Rebecca Thurlow SYDNEY--Mayne Pharma Group Ltd. (MYX.AU) said Wednesday it has launched its foam dermatology products Fabior and Sorilux in the U.S., after acquiring the marketing rights from...

11 January 2017
Dow Jones News

Mayne Pharma to buy 42 drugs

/newsletter/barneyc/476/mayne-pharma-to-buy-42-drugs

03 November 2016
Newspaper

Mayne Pharma Acquires Rights to a Portfolio of Dermatology Foam Products Including Fabior® and Sorilux®

Mayne Pharma Group Limited (“Mayne Pharma”) (ASX: MYX) has acquired a portfolio of dermatology foam products and related assets (“Foam Assets”) from GlaxoSmithKline (“GSK”) for US$50.1...

18 August 2016
Business Wire

Mayne Pharma Buys US Drugs from Teva, Allergan for $652 Million

By Rebecca Thurlow SYDNEY--Mayne Pharma Group Ltd. (MYX.AU) acquired a portfolio of U.S. generic drugs from Teva Pharmaceutical Industries Ltd. (TEVA) and Allergan PLC (AGN) for US$652 million...

28 June 2016
Dow Jones News

Asian Shares Mostly Higher

Australian shares are nearing their highest level since late October on Monday, though falling commodities prices muted gains triggered by stimulus hopes in Europe. The S&P/ASX 200 rose 0.4...

23 November 2015
Dow Jones News

3 stocks in the buy zone and 1 to avoid

http://www.fool.com.au/2015/05/07/3-stocks-in-the-buy-zone-and-1-to-avoid/

07 May 2015
The Motley Fool

Actavis Earnings Soar as Closing of Allergan Deal Looms

By Michael Calia Actavis PLC raised its profit guidance for 2015, while acquisitions again helped drive revenue growth in the fourth quarter, as the company awaits the close of its deal to buy...

18 February 2015
Dow Jones News

Actavis to Divest U.S. Doryx Rights Before Allergan Deal

Actavis PLC (ACT) will sell the U.S. rights to an acne treatment as it seeks to refine its dermatology portfolio ahead of its purchase of Botox maker Allergan Inc. The Doryx deal, valued at about...

10 February 2015
Dow Jones News

Actavis to Divest Itself of U.S. Doryx Rights Ahead of Allergan Deal -- Update

By Maria Armental and Robb M. Stewart Actavis PLC (ACT) will sell the U.S. rights to a acne treatment as it seeks to refine its dermatology portfolio ahead of its purchase of Botox maker Allergan...

10 February 2015
Dow Jones News

HedgePath Pharmaceuticals Welcomes Three New Board Members

HedgePath Pharmaceuticals Welcomes Three New Board Members Stefan Cross, Dr. Dana Ono and Mark Watson add significant biotechnology, capital markets and public accounting expertise to HPPI's...

27 June 2014
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.2856.23632385124.574.94.43823504.54297305DE
40.2455.314533622564.614.94.321381574.5783459DE
120.1853.961456102784.675.343.741640244.53780599DE
26-2.105-30.24425287366.967.463.742105865.11478638DE
521.84561.29568106313.017.462.752409415.22212305DE
1564.5451466.129032260.317.460.1918240910.62796648DE
2604.255709.1666666670.67.460.1928668900.47212033DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVUNanoveu Limited
AUD 0.045
(109.30%)
46.06M
AAUOAntilles Gold Limited
AUD 0.002
(100.00%)
8.38M
A1GAfrican Gold Limited
AUD 0.095
(97.92%)
94.58M
RSHORespiri Limited
AUD 0.015
(66.67%)
2.38M
BNROABulletin Resources Limited
AUD 0.015
(50.00%)
33.33k
MTBMount Burgess Mining Nl
AUD 0.001
(-50.00%)
182.86k
RMLResolution Minerals Ltd
AUD 0.001
(-50.00%)
4.23M
AZLOArizona Lithium Ltd
AUD 0.002
(-33.33%)
1.61M
OAROAR Resources Limited
AUD 0.002
(-33.33%)
2.14M
PRXProdigy Gold NL
AUD 0.002
(-33.33%)
332.33k
A1GAfrican Gold Limited
AUD 0.095
(97.92%)
94.58M
ADNOCAndromeda Metals Limited
AUD 0.002
(0.00%)
69.63M
NVUNanoveu Limited
AUD 0.045
(109.30%)
46.06M
VARRVariscan Mines Limited
AUD 0.001
(0.00%)
35M
POSPoseidon Nickel Limited
AUD 0.0045
(12.50%)
33.31M

Discussion

View Full Feed
JanathanDapo85 JanathanDapo85 2 minutes ago
LWLG still in (-1.03%)
LWLG
JanathanDapo85 JanathanDapo85 2 minutes ago
AAPJ one more system added
AAPJ
GLENO34 GLENO34 2 minutes ago
At the 15 min 50MA again..Will it act as support again??



https://schrts.co/VMWweEww
JoshTaeger JoshTaeger 2 minutes ago
Yes and?

Trump Steaks anyone? Trump University?
And a “charity” that had to be shut down by NYS? That’s business, too.
DJT
SHEEPWOLF SHEEPWOLF 2 minutes ago
$CLNV IT'S NOT ALWAYS EASY BUT SOME PEOPLE STAY UNTIL THE JOB IS DONE.

•GLOBAL PCN: HUGE VENTURE/HUGE POTENTIAL GAINS

•When Dan (CEO) announces $15M W.V. funding we are talking "game changer"

The stock is in a strong up trend.
I'm here to see what
CLNV
tw0122 tw0122 2 minutes ago
Back in $8.08 -fifteen (1:15) reverse split of the Company’s issued and outstanding shares of Common Stock, which will be effective at market open on Nasdaq on October 14, 2024.
PIXY
Gus1212 Gus1212 3 minutes ago
Won't happen because investors will not let that happen

DCVAX WORKS AND SAVES LIVES
NWBO
JanathanDapo85 JanathanDapo85 3 minutes ago
PSRU amazing
PSRU
getmoreshares getmoreshares 3 minutes ago
likely!
Wade probably dumped the shares he converted at the end of September
VTXB
Brickwall10 Brickwall10 3 minutes ago
Italian news!!

https://finanza.lastampa.it/News/2024/10/15/mexedia-reverse-takeover-della-statunitense-raadr-previsto-uplisting-al-nasdaq/MTQxXzIwMjQtMTAtMTVfVExC

Mexedia, reverse takeover of the US Raadr. Uplisting to Nasdaq planned
Published on 10/15/2024
RDAR
Money hunt Money hunt 3 minutes ago
Looking at l2 no shares available gap up is coming
FOXO
serafino1 serafino1 3 minutes ago
Hello Ray
It is true, our representative was present in Judge MW's courtroom and he told us directly LIVE, yes Rose said it word for word. it amazes me that some here on the forum respond to people with mole-like functions and more.
Both RON and AZC. do well not to waste their time wit
COOP
linkvest linkvest 3 minutes ago
🤮
RDAR
CancunCharlie CancunCharlie 3 minutes ago
I don't see anything new yet for today..... but the day is still young!
https://www.nanopharmaceutics.com/triapine
TGRP
Chiron Chiron 3 minutes ago
I still feel in my bones we test .002 here soon…
ASII
THall THall 3 minutes ago
Happens daily with KEGS. Its most likely someone having their broker remove their shares from their portfolio for tax loss purposes
KEGS
haha11 haha11 3 minutes ago
$UPRO 15.....VS ....VIX...IS that daily Bloody W6DN..??? will see.


https://schrts.co/qwcAGWES
UPRO VIX
gilead23 gilead23 4 minutes ago
DRX.TO/ADFJF threatening to break below 10. I’m avoiding this falling knife right now, but I think there may eventually be a buying opportunity here when we get a little more clarity. On paper it’s dirt cheap, and I suspect it would rip violently up with any evidence the cycle isn’t turning on them.
ADFJF
ipiros ipiros 4 minutes ago
https://x.com/northbayres/status/1846198750215356558?s=46&t=1mtQtgXmx35-BlWutjUYiQ
NBRI
arachnodude arachnodude 4 minutes ago
It's laughable how you claim I need an extensive crow platter when, in reality, my points are perfectly aligned with the facts the company has laid out. Meanwhile, you’re out here twisting and obfuscating every shred of progress to fit your doom-and-gloom agenda.

The real crow party w
KBLB
JohnnyRothrock JohnnyRothrock 4 minutes ago
RM News hit Italian financial. newspaper La Stampa:


https://finanza.lastampa.it/News/2024/10/15/mexedia-reverse-takeover-della-statunitense-raadr-previsto-uplisting-al-nasdaq/MTQxXzIwMjQtMTAtMTVfVExC

i guess getting red days out of way ? crazy! International big
RDAR
SCAMBUSTERKING SCAMBUSTERKING 4 minutes ago
Yup, I am always weary of people on here. The number of death threats I have received from folks is crazy, just for pointing out they are being scammed. Jakey has already been in contact with some of those groups through his lawyer, it is being reported by them as a threat at me as well. So I will a
SONG

Your Recent History

ASX
MYX
Mayne Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved